-
The duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction.
Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, Baschat AA.
Ultrasound Obstet Gynecol 2011;38:295-302. -
Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates.
Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH.
Prenat Diagn 2011;31:58-65. -
Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects.
Pereira S, Ganapathy R, Syngelaki A, Maiz N, Nicolaides KH.
Obstet Gynecol 2011;117:1384-91. -
Maternal serum adiponectin at 11-13 weeks of gestation in pregnancies delivering small for gestation neonates.
Nanda S, Akolekar R, Sodre D, Vaikousi E, Nicolaides KH.
Fetal Diagn Ther 2011;29:274-9. -
Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks.
Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH.
Fetal Diagn Ther 2011;29:148-54. -
Maternal thyroid function at eleven to thirteen weeks of gestation and subsequent delivery of small for gestational age neonates.
Karagiannis G, Ashoor G, Maiz N, Jawdat F, Nicolaides KH.
Thyroid 2011;21:1127-31. -
Association of placental volume measured by MRI and birth weight percentile.
Derwig IE, Akolekar R, Zelaya FO, Gowland PA, Barker GJ, Nicolaides KH.
J Magn Reson Imaging 2011;34:1125-30. -
Contribution of ductus venosus doppler in first-trimester screening for major cardiac defects.
Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH.
Fetal Diagn Ther 2011;29:127-34. -
Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.
Bombard AT, Akolekar R, Farkas DH, Vanagtmael AL, Aquino F, Oeth P, Nicolaides KH.
Prenat Diagn 2011;31:802-8. -
Fetal RHD Genotyping in Maternal Plasma at 11-13 Weeks of Gestation.
Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH.
Fetal Diagn Ther 2011;29:301-6. -
Assessment of the corpus callosum at 20-24 weeks' gestation by three-dimensional ultrasound examination.
Plasencia W, Dagklis T, Borenstein M, Csapo B, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:169-72. -
Nuchal translucency and the risk of congenital heart disease.
Hyett J, Sonek J, Nicolaides KH.
Obstet Gynecol 2007;109:1455-6. -
Predictors of neonatal outcome in early-onset placental dysfunction.
Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Muller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR.
Obstet Gynecol 2007;109:253-61. -
Maternal cardiac function in fetal growth-restricted and non-growth-restricted small-for-gestational age pregnancies.
Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;29:51-57. -
Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1550-6. -
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction.
Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1668-73. -
Fetal growth restriction and postnatal development.
Eleftheriades M, Creatsas G, Nicolaides K.
Ann N Y Acad Sci 2006;1092:319-30. -
Maternal cardiac function in fetal growth restriction.
Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH.
BJOG 2006;113:784-91.